Immunoglobulin E News Today

Understanding the cause and mechanism of seasonal allergy can help in choosing the right treatment.

Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.

A new study failed to find an association between prior exposure to tick bites and chronic musculoskeletal symptoms and radiographic measures of osteoarthritis.

Patients who have extrinsic (EAD) or intrinsic atopic dermatitis (IAD) serve to benefit equally from dupilumab, even when considering immunoglobulin E levels, which are elevated in EAD but remain normal in IAD.

Despite the approval of dupilumab (Dupixent) in September 2022, there is an ongoing dearth of clinically effective treatments for prurigo nodularis, prompting the present investigation of the monoclonal antibody for the chronic inflammatory skin condition.

Today, the U.S. Food and Drug Administration issued a draft guidance that, when finalized, will outline the agency’s approach to evaluating the public health importance of food allergens that are not one of the major nine food allergens identified by law in the U.S (non-listed food allergens). 

When he’s explaining oral immunotherapy, Dr. Daniel Soteres will quote lines from The Princess Bride. It’s the part where the Man in Black wins a battle of wits against the

Abstract Aim: To conduct a prospective, consecutive cohort study to evaluate the incidence of allergen-specific and total immunoglobulin E (IgE) in a paediatric population undergoing adenotonsillectomy for sleep-disordered breathing. Methods: A total of 64 consecutive patients presenting for adenotonsillectomy at a single centre were recruited over a period of 3 months. All patients underwent adenotonsillectomy and had allergen-specific and total IgE serum testing at the time of anaesthesia ind...